Anthony Pitt

Anthony Pitt Email and Phone Number

Chief Technology Officer at Orbit Discovery Ltd @ Orbit Discovery
Anthony Pitt's Location
Nottinghamshire, England, United Kingdom, United Kingdom
Anthony Pitt's Contact Details
About Anthony Pitt

Anthony Pitt is a Chief Technology Officer at Orbit Discovery Ltd at Orbit Discovery. He possess expertise in drug discovery, biotechnology, technology transfer, lifesciences, cell culture and 20 more skills. Colleagues describe him as "Ant is the best assay developer with whom I've worked. He is extremely innovative and has practical sense. He is a world class expert in bioluminescent technologies and their use for detection. The assays Ant designed and developed have been run in HT screens many times. Ant would be an outstanding contributor to phenotypic screening assay programs.", "Anthony is one of those rare R&D scientists who thinks across disciplines to routinely come up with simple, pragmatic solutions to the challenges facing our customers. He has a very broad knowledge base and he has invented/developed some very successful products.", and "I worked with Anthony for about 2 years at Lonza. He is an excellent scientist who combines deep and detailed scientific knowledge with highly innovative thinking. He used these skills in combination with his profound strategic thinking to lead his projects to success.I can highly recommend Anthony as a highly skilled professional and colleague who is a lot of fun to work with."

Anthony Pitt's Current Company Details
Orbit Discovery

Orbit Discovery

View
Chief Technology Officer at Orbit Discovery Ltd
Anthony Pitt Work Experience Details
  • Orbit Discovery
    Chief Technology Officer
    Orbit Discovery Nov 2017 - Present
    Oxford, Gb
    Orbit Discovery Ltd is a spin-out from the University of Oxford. Our technology is an enhanced DNA-encoded peptide display technology which was developed by Prof Graham Ogg at the Weatherall Institute of Molecular Medicine to address the need for a display technology able to probe the cell surface. The initial objective was to present random peptides to T-cells with unknown specificity as a way to establish their epitopes – something that was impossible with phage display or mRNA display.The technology supports the presentation of natural amino acids, non-natural amino acids, linear peptides, constrained peptides and peptides modified after translation.Our business model is simple – establish both internal discovery programmes which we will out-license in the future and collaborative programmes with industry and academia. We aim to balance the two through the efficiency that our technology enables and identify well characterised, selective hits for existing and novel drug targets wherever a peptide might make sense.
  • Orbit Discovery
    Consultant
    Orbit Discovery Feb 2016 - Oct 2017
    Oxford, Gb
  • Useful Biology Ltd
    Owner And Technical Director
    Useful Biology Ltd Apr 2013 - Nov 2017
    Developing novel molecular diagnostic and enzymatic bioassays for pathogens directly affecting human health, the human food supply and life science research.
  • Lonza Bioscience
    Technical Director, Assays And Technology Development
    Lonza Bioscience 2008 - 2012
    Basel, Ch
    Strategic planning of research & development, marketing and sales activities for the drug discovery business unit.Establishment of a cell based assays program via internal development and in-licensing of new technologies.Promoting drug discovery business unit technologies and services via presentations at conferences, meetings, direct to biotech and pharma customers and by the internet.Determining client needs and the subsequent design of plans for custom assay development and compound profiling projects.Assessment of the drug discovery market in terms of needs, competitor technologies and intellectual property.Technical and competitor training of a focussed drug discovery sales and marketing team.Identification of external partners in the drug discovery field for collaborative projects (outsourcing Lonza technologies, insourcing external technologies).
  • Lonza Nottingham
    Director Of Research And Development
    Lonza Nottingham 2007 - 2008
    Management of R&D projects, manufacturing and QC activities at Nottingham site and related activities at US sites.Invention and development of bioluminescent biochemical and cell based assays for the research, product release testing and drug discovery markets.Intellectual property: writing patents and patent applications and assessment of competitor IP.Protein engineering including cloning, mutagenesis, fermentation, expression, purification and characterization.Support of marketing and sales activities.
  • Cambrex Bioscience Nottingham
    Director Of Research And Development
    Cambrex Bioscience Nottingham 2003 - 2007
    Responsible for the development of bioluminescent bioassays for the research and drug discovery markets (see above). Company acquired by Lonza in 2007.
  • Cambrex Bioscience Nottingham
    Research And Development Manager
    Cambrex Bioscience Nottingham 2001 - 2003
    Development of bioluminescent based assays related to cell health and function and specific characterizations of purified enzymes.Management of a team of 5 R&D scientists.Development of manufacturing and QC processes.
  • Lumitech Ltd
    Research And Development Manager
    Lumitech Ltd 1998 - 2001
    Responsible for the development of bioluminescent bioassays for the research and drug discovery markets (see above). Company acquired by Cambrex Bioscience.
  • University Of Nottingham
    Scientific Researcher
    University Of Nottingham 1992 - 1998
    Nottingham, Gb
    Research into the molecular and cell biology of asthma and cystic fibrosis.

Anthony Pitt Skills

Drug Discovery Biotechnology Technology Transfer Lifesciences Cell Culture R&d Biochemistry Cell Biology Molecular Biology Protein Chemistry Assay Development Cell Purification Drug Development Elisa Protein Purification Genomics Microbiology Patents Validation Biopharmaceuticals Bioinformatics Commercialization Immunology Life Sciences

Anthony Pitt Education Details

  • University Of Nottingham
    University Of Nottingham
    Biochemistry And Genetics

Frequently Asked Questions about Anthony Pitt

What company does Anthony Pitt work for?

Anthony Pitt works for Orbit Discovery

What is Anthony Pitt's role at the current company?

Anthony Pitt's current role is Chief Technology Officer at Orbit Discovery Ltd.

What is Anthony Pitt's email address?

Anthony Pitt's email address is ap****@****aol.com

What is Anthony Pitt's direct phone number?

Anthony Pitt's direct phone number is +130180*****

What schools did Anthony Pitt attend?

Anthony Pitt attended University Of Nottingham.

What skills is Anthony Pitt known for?

Anthony Pitt has skills like Drug Discovery, Biotechnology, Technology Transfer, Lifesciences, Cell Culture, R&d, Biochemistry, Cell Biology, Molecular Biology, Protein Chemistry, Assay Development, Cell.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.